Increase in the ability of human cancer cells to induce cytotoxic T lymphocytes by ultraviolet irradiation

Alexander J, Edinger M, Connelly R, Tubbs R, Pontes E, Bukowski R, Finke J (1990) Isolation of activated CD8+ cells from PBL and tumor-infiltrating lymphocytes (TIL) from renal cell carcinoma (RCC) and their characterization. FASEB J 4: A2021 Alexander J, Rayman P, Edinger M, Connelly R, Tubbs R, Bukowski R, Pontes E, Finke J (1990) TIL from renal cell carcinoma: restimulation with tumor influences proliferation and cytotoxic activity. Int J Cancer 45: 119–124 Anichini A, Mazzocchi A, Fossati G, Parmiani G (1984) Cytotoxic T lymphocyte clones from peripheral blood and from tumor site detect intratumor heterogeneity of melanoma cells. Analysis of specificity and mechanisms of interaction. J Immunol 142: 3692–3701 Applegate LA, Lee RD, Alcalay J, Kripke ML (1989) Identification of the molecular target for the suppression of contact hypersensitivity by ultraviolet radiation. J Exp Med 170: 1117–1131 Augusts LB, Hayakawa K, von eschenbach AC, Swanson DA, Itoh K (1992) Increase in immunogenicity of human renal cell carcinoma cells by exposure to ultraviolet-B radiation. Proc Amer Assoc Cancer Res 33: 334 Balch CM, Riley LB, Bae Y-J, Salmeron MA, Platsoucas CD, von Eschenbach AC, Itoh K (1990) Patterns of human tumor-infiltrating lymphocytes in 120 human cancers. Arch Surg 125: 200–205 Belldegrun A, Muul LM, Rosenberg SA (1988) Interleukin 2 expanded tumor-infiltrating lymphocytes in human renal cell carcinoma: isolation, characterization, and antitumor activity. Cancer Res 47: 206–214 Belldegrun A, Kasid A, Uppenkamp M, Topalian SL, Rosenberg SA (1989) Human tumor-infiltrating lymphocytes. Analysis of lymphokine mRNA expression and relevance to cancer immunotherapy. J Immunol 142: 4520–4526 Bonmasser VE, Bonmasser A, Vadlamudi S, Goldin A (1970) Immunologic alteration of leukemic cells in vivo after treatment with an antitumor drug. Proc Natl Acad Sci USA 66: 1089–1095 Boone C, Blackman K (1972) Augmented immunogenicity of tumor cell homogenates infected with influenza virus. Cancer Res 32: 1018–1022 Boon T, Kellerman O (1977) Rejection by syngeneic mice of cell variants obtained by mutagenesis of a malignant teratocarcinoma cell line. Proc Natl Acad Sci USA 74: 272–275 Carlow DA, Kerbel RS, Feltis JT, Elliott BD (1985) Enhanced expression of class I major histocompatibility complex gene (Dk) products on immunogeneic variants of a spontaneous murine carcinoma. J Natl Cancer Inst 75: 291–300 Contessa AR, Bonmasser A, Giampietri A, Circolo A, Goldin A, Fioretti MC (1981) In vitro generation of a highly immunogenic subline of L1210 leukemia following exposure to 5-(3′-dimethyl-triazeno)imidazole-4-carboxamide. Cancer Res 41: 2476–2482 Darrow TL, Slingluff CL, Seigler HF (1989) The role of HLA class I antigens in recognition of melanoma cells by tumor-specific cytotoxic T lymphocytes; evidence for shared tumor antigens. J Immunol 142: 3329–3335 Daynes RA, Schmitt MK, Roberts LK, Spellman CW (1979) Phenotypic and physical characteristics of the lymphoid cells involved in the immunity to syngeneic UV-induced tumors. J Immunol 122: 2458–2464 Fearon ER, Pardoll DM, Itaya T, Golumbek P, Levitsky HI, Simons JW, Karasuyama H, Vogelstein B, Frost P (1990) Interleukin-2 production by tumor cells bypasses T helper function in the generation of an anti-tumor response. Cell 60: 397–402 Finke JH, Rayman P, Alexander J, Edinger M, Tubbs RR, Connelly R, Pontes E, Bukowski R (1990) Characterization of the cytotoxic activity of CD4+ and CD8+ tumor-infiltrating lymphocytes in human renal cell carcinoma. Cancer Res 50: 2363–2370 Fisher MS (1978) A systemic effect of UV-irradiation and its relationship to tumor immunity. Natl Cancer Inst Monogr 50: 185–188 Fishleder AJ, Finke JH, Tubbs R, Bukowski RM (1990) Induction by interleukin-2 of oligoclonal expansion of cultured tumor-infiltrating lymphocytes. J Natl Cancer Inst 82: 124–128 Fortner GW, Kripke ML (1977) In vitro reactivity of splenic lymphocytes from normal and UV-irradiated mice against syngeneic UV-induced tumors. J Immunol 118: 1483–1487 Frost P, Kerbel RS, Bauer E, Tartamella-Biondo R, Cefalu W (1983) Mutagen treatment as a means for selecting immunogenic variants from otherwise poorly immunogenic malignant murine tumors. Cancer Res 43: 125–132 Fuji H, Mihich E (1975) Selection for high immunogenicity in drugresistant sublines of murine lymphomas demonstrated by plaque assay. Cancer Res 35: 946–952 Graffi A, Pasternak G, Horn K-H (1964) Die Erzeugung von Resistenz gegen infolge transplantierter UV-induzierter Sarkome der Maus. Acta Biol Med Ger 12: 726–732 Hayakawa K, Salmeron MA, Parkinson DR, Markowitz AB, von Eschenbach AC, Legha SS, Balch CM, Ross MI, Augustus LB, Itoh K (1991) Study of tumor-infiltrating lymphocytes for adoptive therapy of renal cell carcinoma (RCC) and metastatic melanoma. Sequential proliferation of cytotoxic natural killer and noncytotoxic T cells in RCC. J Immunother 10: 313–325 Hayakawa K, Morita T, Augustus LB, von Eschenbach AC, and Itoh K (1992) Human renal cell carcinoma cells are able to activate natural killer cells. Int J Cancer 51: 290–295 Hersey P, MacDonald M, Schibeci S, Burns C (1986) Clonal analysis of cytotoxic T lymphocytes (CTL) against autologous melanoma. Cancer Immunol Immunother 22: 15–23 Hostetler LW, Kripke ML (1987) Origin and significance of transplantation antigens induced on cells transformed by UV radiation: In: Greene MI, Hamaoka T (eds), Development and recognition of the transformed cells, Plenum, New York, pp 307–329 Hostetler LW, Kripke ML (1988) Proportion of antigenic variants indued by in vitro UV irradiation differs in clones derived from a single tumor. J Immunol 140: 666–670 Hostetler LW, Ananthaswamy HN, Kripke ML (1986) Generation of tumor-specific transplantation antigens by UV radiation can occur independently of neoplastic transplantation. J Immunol 137: 2721–2725 Hui K, Grosveld F, Festenstein H (1985) Rejection of transplantable AKR leukemia cells following MHC DNA-mediated cell transformation. Nature 311: 750–752 Itoh K, Platsoucas CD, Balch CM (1988) Autologous tumor-specific cytotoxic T lymphocytes in the infiltrates of human metastatic melanoma. Activation by interleukin 2 and autologous tumor cells, and involvement of the T cell receptor. J Exp Med 168: 1419–1441 Kerbel RS (1979) Immunologic studies of membrane mutants of a highly metastatic murine tumor. Am J Pathol 97: 609–622 Kobayashi H, Sendo F, Shirai T, Kaji H, Kodama T (1969) Modification in growth of transplantable rat tumors exposed to friend virus. J Natl Cancer Inst 42: 413–418 Kripke ML (1974) Antigenicity of murine skine tumors induced by ultraviolet light. J Natl Cancer Inst 53: 1333–1336 Kripke ML (1977) Latency, histology, and antigenicity of tumors induced by ultraviolet light in three inbred mouse strains. Cancer Res 37: 1395–1399 Lindermann J, Klein P (1967) Viral oncolysis: increased immunogenicity of host cell antigen associated with influenza virus. J Exp Med 126: 93–108 Mansfield PF, Salmeron MA, Rosenblum MG, Itoh K (1991) Effects of HC antibody in autologous tumor-specific cytotoxicity by human melanoma tumor-infiltrating lymphocytes. Int J Cancer 49: 356–361 Patrick MH, Rahn RO (1976) Photochemistry of DNA and polynucleotides: photoproducts. In: Wang SY (ed), Photochemistry and photobiology of nucleic acid, vol 2. Academic Press, New York, pp 35–95 Peppoloni S, Herberman RB, Gorelik E (1985) Induction of highly immunogenic variants of Lewis lung carcinoma by ultraviolet irradiation. Cancer Res 45: 2526–2536 Schmid FA, Hutchison DJ (1973) Decrease in oncogenic potential of L1210 leukemia by triazenes. Cancer Res 33: 2161–2165 Tepper RI, Pattengale PK, Leder P (1989) Murine interleukin 4 displays potent anti-tumor activity in vivo. Cell 57: 503–512 Thorn RT (1978) Specific inhibition of cytotoxic memory cells produced against UV-induced tumors in UV irradiated mice. J Immunol 121: 1920–1926 Uyttenhove C, Van Snick J, Boon T (1980) Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. I. Rejection by syngeneic mice. J Exp Med 152: 1175–1183 Van Pel A, Vessiere F, Boon T (1983) Protection against two spontaneous mouse leukemias conferred by immunogenic variants obtainead by mutagenesis. J Exp Med 457: 1992–2001 Wallich R, Bulbuc N, Hammerling GJ, Katsav S, Segel S, Feldman M (1985) Abrogation of metastatic properties of tumor cells by de novo expression of H-2 K antigens following H-2 gene transfection. Nature 315: 301–305 Weber JS, Jay G, Tanaka K, Rosenberg RA (1987) Immunotherapy of a murine tumor with interleukin 2. Increased sensitivity after MHC Class I gene transfection. J Exp Med 166: 1716–1733 Wortzel RD, Urban JL, Schreiber H (1984) Malignant growth in the normal host after variant selection in vitro with cytolytic T-cell lines. Proc Natl Acad Sci USA 81: 2186–2190